QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, December 31, 2008, 28(53):14500-14510; doi:10.1523/JNEUROSCI.5141-08.2008

This Article Full Text Full Text (PDF) Supplemental Data Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (10) Citing Articles via Google Scholar Google Scholar Articles by Yun, J. Articles by Guo, M. Search for Related Content PubMed PubMed Citation Articles by Yun, J. Articles by Guo, M.

 Previous Article  |  Next Article 

Neurobiology of Disease
Loss-of-Function Analysis Suggests That Omi/HtrA2 Is Not an Essential Component of the pink1/parkin Pathway In Vivo

Jina Yun,^1,2 Joseph H. Cao,¹ Mark W. Dodson,^1,4 Ira E. Clark,¹ Pankaj Kapahi,⁵ Ruhena B. Chowdhury,⁶ and Ming Guo^1,2,3,4

Departments of ¹Neurology and ²Molecular and Medical Pharmacology and ³Brain Research Institute, The David Geffen School of Medicine, and ⁴Molecular Biology Institute, University of California, Los Angeles, Los Angeles, California 90095, ⁵Buck Institute for Age Research, Novato, California 94945, and ⁶Cancer Research UK, London Research Institute, London WC2A 3PX, United Kingdom

Correspondence should be addressed to Dr. Ming Guo, Departments of Neurology and Molecular and Medical Pharmacology, University of California, Los Angeles, 695 Charles Young Drive South, Los Angeles, CA 90095. Email: mingfly{at}ucla.edu

Recently, a mutation in the mitochondrial protease Omi/HtrA2, G399S, was found in sporadic Parkinson's disease (PD) patients, leading to the designation of Omi/HtrA2 as PD locus 13 (PARK13). G399S reportedly results in reduced Omi protease activity. In vitro studies have suggested that Omi/HtrA2 acts downstream of PINK1, mutations in which mediate recessive forms of PD. We, as well as other, have previously shown that the Drosophila homologs of the familial PD genes, PINK1 (PARK6) and PARKIN (PARK2), function in a common genetic pathway to regulate mitochondrial integrity and dynamics. Whether Omi/HtrA2 regulates mitochondrial integrity and whether it acts downstream of PINK1 in vivo remain to be explored. Here, we show that Omi/HtrA2 null mutants in Drosophila, in contrast to pink1 or parkin null mutants, do not show mitochondrial morphological defects. Extensive genetic interaction studies do not provide support for models in which Omi/HtrA2 functions in the same genetic pathway as pink1, or carries out partially redundant functions with pink1, at least with respect to regulation of mitochondrial integrity and dynamics. Furthermore, Omi/HtrA2 G399S retains significant, if not full, function of Omi/HtrA2, compared with expression of protease-compromised versions of the protein. In light of recent findings showing that G399S can be found at comparable frequencies in PD patients and healthy controls, we do not favor a hypothesis in which Omi/HtrA2 plays an essential role in PD pathogenesis, at least with respect to regulation of mitochondrial integrity in the pink1/parkin pathway.

Key words: Parkinson's disease; mitochondrial protease; Omi/HtrA2; Pink1; genetic interactions; Drosophila

---

Received Oct. 24, 2008; revised Nov. 29, 2008; accepted Dec. 1, 2008.

Correspondence should be addressed to Dr. Ming Guo, Departments of Neurology and Molecular and Medical Pharmacology, University of California, Los Angeles, 695 Charles Young Drive South, Los Angeles, CA 90095. Email: mingfly{at}ucla.edu

This article has been cited by other articles:

				J. Park, Y. Kim, and J. Chung Mitochondrial dysfunction and Parkinson's disease genes: insights from Drosophila Dis. Model. Mech., July 1, 2009; 2(7-8): 336 - 340. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help